Quick Links

Supported by City of Hope's NCI-funded Cancer Center Support Grant (CCSG)

 SNP Genotyping

Capacity for single nucleotide polymorphism (SNP) genotyping can run from the small-scale analysis of a few hundred SNPs to large projects with over 10,000 SNPs. We provide options for investigators that take into account both the number of patient samples to be genotyped and the number of desired SNPs to be analyzed. All SNP genotyping projects will employ the Sequenom MassARRAY iPLEX Gold system.

Highlights include:

  • Multiplex PCR amplification and robust single-base primer extension biochemistry with the sensitivity and accuracy of MALDI-TOF MS detection.
  • Assays can be multiplexed up to 30 SNPs in one individual reaction allowing for high-throughput levels and reduced chemistry cost and dependent upon assay design.
  • Oligonucleotides are unlabeled and of standard quality.

Applications for iPLEX Genotyping Include:

  • Mutation Detection
  • Copy number variants analysis (CNV)
  • Insertion/Deletions
  • Disease association studies (follow up to GWAS)
  • Loss of heterozygosity analysis
  • Allelotyping of pooled samples

A brief description of the protocol can be found in the SNP Genotyping Brochure.

 Search

Go!
Advanced Search Options
News & Publications Search
NCI CCC LogoCity of Hope is one of 40 Comprehensive Cancer Centers, the highest designation bestowed by the National Cancer Institute and a recognition of excellence in cancer treatment, research, prevention and education.
City of Hope strongly supports and values the uniqueness of all individuals and promotes a work environment where diversity is embraced.
NCI CCC LogoThe National Comprehensive Cancer Network®
(NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HON code of the Healthcare on the Net Foundation.